More should be done to prevent the harmful effects of long-term androgen ablation therapy in prostate cancer

被引：7
作者：
Barrass, BJR [1 ]
Thurairaja, R [1 ]
Persad, RA [1 ]
机构：
[1] Univ Bristol, Div Surg, Bristol BS2 8HW, Avon, England
来源：
BJU INTERNATIONAL | 2004年 / 93卷 / 09期
关键词：
D O I：
10.1111/j.1464-410X.2004.04888.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1175 / 1176
页数：2
相关论文
共 14 条
[1]  
[Anonymous], 1997, Br J Urol, V79, P235
[2]  
[Anonymous], IMPR OUTC UR CANC MA
[3]   Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial [J].
Bolla, M ;
Collette, L ;
Blank, L ;
Warde, P ;
Dubois, JB ;
Mirimanoff, RO ;
Storme, G ;
Bernier, J ;
Kuten, A ;
Sternberg, C ;
Mattelaer, J ;
Torecilla, JL ;
Pfeffer, JR ;
Cutajar, CL ;
Zurlo, A ;
Pierart, M .
LANCET, 2002, 360 (9327) :103-108
[4]  
Dalesio O, 2000, LANCET, V355, P1491
[5]   Osteoporosis after orchiectomy for prostate cancer [J].
Daniell, HW .
JOURNAL OF UROLOGY, 1997, 157 (02) :439-444
[6]   Bone loss and the evolving role of bisphosphonate therapy in prostate cancer [J].
Higano, CS .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2003, 21 (05) :392-398
[7]   Skeletal fractures negatively correlate with overall survival in men with prostate cancer. [J].
Oefelein, MG ;
Ricchiuti, V ;
Conrad, W ;
Resnick, MI .
JOURNAL OF UROLOGY, 2002, 168 (03) :1005-1007
[8]   Skeletal fracture associated with androgen suppression induced osteoporosis: The clinical incidence and risk factors for patients with prostate cancer [J].
Oefelein, MG ;
Ricchuiti, V ;
Conrad, W ;
Seftel, A ;
Bodner, D ;
Goldman, H ;
Resnick, M .
JOURNAL OF UROLOGY, 2001, 166 (05) :1724-1728
[9]   Alendronate for the treatment of osteoporosis in men [J].
Orwoll, E ;
Ettinger, M ;
Weiss, S ;
Miller, P ;
Kendler, D ;
Graham, J ;
Adami, S ;
Weber, K ;
Lorenc, R ;
Pietschmann, P ;
Vandormael, K ;
Lombardi, A ;
Adachi, JD ;
Bell, N ;
Body, JJ ;
Castro, A ;
Daifotis, A ;
Felsenberg, D ;
Gilchrist, N ;
Hoffman, A ;
Maricic, M ;
Rizzoli, R ;
Silverman, S ;
Valeriano, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (09) :604-610
[10]   Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer [J].
Smith, MR ;
Eastham, J ;
Gleason, DM ;
Shasha, D ;
Tchekmedyian, S ;
Zinner, N .
JOURNAL OF UROLOGY, 2003, 169 (06) :2008-2012
12